Castleview Partners’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-470
| Closed | -$20.8K | – | 258 |
|
2024
Q4 | $20.8K | Buy |
470
+73
| +18% | +$3.23K | 0.01% | 465 |
|
2024
Q3 | $25K | Buy |
397
+3
| +0.8% | +$189 | 0.01% | 413 |
|
2024
Q2 | $23.3K | Sell |
394
-381
| -49% | -$22.5K | 0.01% | 421 |
|
2024
Q1 | $61.8K | Buy |
775
+20
| +3% | +$1.6K | 0.03% | 325 |
|
2023
Q4 | $59.6K | Buy |
755
+587
| +349% | +$46.4K | 0.04% | 274 |
|
2023
Q3 | $11.7K | Sell |
168
-253
| -60% | -$17.7K | 0.01% | 410 |
|
2023
Q2 | $29.1K | Buy |
421
+102
| +32% | +$7.05K | 0.03% | 324 |
|
2023
Q1 | $23.7K | Buy |
319
+1
| +0.3% | +$74 | 0.02% | 323 |
|
2022
Q4 | $29.7K | Buy |
318
+221
| +228% | +$20.6K | 0.03% | 269 |
|
2022
Q3 | $9K | Sell |
97
-3
| -3% | -$278 | 0.01% | 390 |
|
2022
Q2 | $2.58K | Buy |
100
+32
| +47% | +$825 | ﹤0.01% | 616 |
|
2022
Q1 | $6K | Sell |
68
-38,823
| -100% | -$3.43M | ﹤0.01% | 549 |
|
2021
Q4 | $377 | Buy |
+38,891
| New | +$377 | ﹤0.01% | 572 |
|
2021
Q2 | $31K | Buy |
+377
| New | +$31K | 0.01% | 488 |
|